Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.55 USD | -0.18% | +0.18% | +8.55% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
Financials (USD)
Sales 2024 * | 448M | Sales 2025 * | 537M | Capitalization | 3.45B |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | 36M | EV / Sales 2024 * | 6.95 x |
Net cash position 2024 * | 329M | Net cash position 2025 * | 370M | EV / Sales 2025 * | 5.73 x |
P/E ratio 2024 * |
-699
x | P/E ratio 2025 * |
96.3
x | Employees | 797 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Axonics, Inc.
1 day | -0.18% | ||
1 week | +0.18% | ||
Current month | +1.47% | ||
1 month | +0.52% | ||
3 months | -0.31% | ||
6 months | +20.00% | ||
Current year | +8.55% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 12-12-31 | |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 19-02-26 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 19-04-07 |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.09% | 430 M€ | -.--% | ||
0.05% | 746 M€ | -.--% | - | |
0.04% | 234 M€ | +5.72% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 67.55 | -0.18% | 236,660 |
24-05-16 | 67.67 | -0.03% | 336,569 |
24-05-15 | 67.69 | +0.36% | 229,729 |
24-05-14 | 67.45 | +0.18% | 403,385 |
24-05-13 | 67.33 | -0.15% | 318,963 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.55% | 3.45B | |
-5.10% | 11.34B | |
+4.02% | 9.11B | |
+38.12% | 5.53B | |
-23.70% | 4.61B | |
-6.44% | 2.87B | |
-5.85% | 2.1B | |
-11.84% | 2.08B | |
-23.36% | 1.78B | |
-9.29% | 1.14B |
- Stock Market
- Equities
- AXNX Stock